Swedish Life Sciences Trend Analysis 2017 About Us

Swedish Life Sciences Trend Analysis 2017

About Us The following statistical information has been obtained from Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. www. biotechgate. com The Nordic Life Sciences Database is a part of the global Biotechgate. Our Swedish partners include Sweden. BIO, Invest in Skåne, Medicon Valley, SWElife, Business Region Göteborg and Sweden Medtech. www. nordic-lifesciences. com Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. www. venturevaluation. com

Overview of the Swedish Life-Science Industry 2017 Statistics Total Biotech Companies 528 Medtech Companies 301 Pharma Companies 44 Investor Companies 27 Public / Non-Profit Organizations / Medical Facilities 124 Other life science related companies 1141 Percentage of Publicly Owned Companies 10. 9% Biotech Venture financing 2016/2017 USD 96. 5 m/ 14. 6 m Life Sciences Venture Financing 2016/2017 USD 113. 2 m/23. 6 m Number of Technologies 113 Licensing Opportunities 107

Overview of the Swedish Biotechnology Industry 2017 Statistics Total Biotech companies 528 Biotech - Therapeutics 167 Biotech – R&D Services 247 Biotech - Other 114 Percentage of SMEs 97% Percentage of publicly owned companies Biotech venture financing 2016/2017 Licensing opportunities 11, 6% USD 95. 5 m / 14. 6 m 92

Number of companies by ownership status Life Science Companies by Ownership Status Biotechnology Companies by Ownership Status Publicly listed on stock exchange 11, 6% Publicly listed on stock exchange 10, 9% Subsidiary 13, 4% Subsidiary 10, 4% Private / independent 75, 7% Private / independent 78, 0%

Company Foundation Timeline Number of Biotech Companies Founded by Year 25 20 15 10 5 Biotechnology - other Biotechnology - Therapeutics and Diagnostics Biotechnology / R&D Services 17 20 16 20 15 20 14 20 13 20 12 20 11 20 20 10 0

Number of Biotechnology Companies by Key Activities Veterinary 821 3, 0% Agro. Bio 1062 3, 9% Bioinformatics and Bioelectronics 982 Contract Research and 3, 6% Manufacturing 3188 11, 6% Therapeutics 4451 16, 2% Other Services and Suppliers 6354 23, 1% Industrial Biotechnology 396 1% Cosmetics 701 2, 5% Diagnostics and Analytical Services 4606 16, 7% Drug Delivery 749 2, 7% Genomics and Proteomics 1753 6, 4% Food and Nutraceuticals 2091 7, 6% Environment 401 1, 5%

Biotech products - Breakdown by Indication Biotech Products by Indication other External causes of morbidity and mortality Injury, poisoning and certain other consequences of external causes Skin and subcutaneous tissue Diseases of the eye Musculoskeletal system and connective tissue Neoplasms / cancer / oncology Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified Mental and behavioural disorders Diseases of the ear 0 25 50 75 100 125

Products in the Pipeline Number of Biotech Products in Development Preclinical 100 Phase I 46 Phase II 71 Phase III 14 0 20 40 60 80 100

Biotechnology Financing in Sweden – 5 year report Venture Financing of Biotech Companies 50, 0 10 Financing Value Number of Rounds 40, 0 30, 0 5 20, 0 10, 0 Financing Value Number of Rounds 2013 H 1 7, 1 3 2013 H 2 17, 3 4 2014 H 1 53, 6 5 2014 H 2 25, 5 8 2015 H 1 8, 0 3 2015 H 2 9, 7 5 2016 H 1 51, 6 3 2016 H 2 44, 9 7 2017 H 1 4, 0 2 2017 H 2 10, 6 2 0 Number of Rounds Financing Value (Million USD) 60, 0

Major Biotech Financing Rounds (H 2 2016 – H 1 2017) Company Sector USD M Ox. Thera AB Biotech – Therapeutics & Diagnostics 33. 9 Dilafor AB Biotech – Therapeutics & Diagnostics 5. 98 Modus Therapeutics Biotech – Therapeutics & Diagnostics 3. 58

About Biotechgate contains over 48, 000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data. To register for a trial or to learn more about the different subscription options, please visit www. biotechgate. com.

Terms of Use The “Swedish Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at www. biotechgate. com. The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof. The use of the figures and graphs provided in this report is free of charge for any presentations as long as www. biotechgate. com is clearly cited as the source. For all other uses please contact us for terms and conditions. Biotechgate c/o Venture Valuation VV AG Kasernenstrasse 11 8004 Zurich Switzerland +41 (43) 321 86 60 www. venturevaluation. com